Results of the Two Incidence Screenings in the National Lung Screening Trial | Zendy

Denise R. Aberle | Zendy; Sarah DeMello | Zendy; Christine D. Berg | Zendy; William C. Black | Zendy; Brenda Brewer | Zendy; Timothy R. Church | Zendy; Kathy L. Clingan | Zendy; Fenghai Duan | Zendy; Richard M. Fagerstrom | Zendy; Ilana F. Gareen | Zendy; Constantine Gatsonis | Zendy; David S. Gierada | Zendy; Amanda Jain | Zendy; Gordon C. Jones | Zendy; Irene Mahon | Zendy; Pamela M. Marcus | Zendy; Joshua M. Rathmell | Zendy; JoRean D. Sicks | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Results of the Two Incidence Screenings in the National Lung Screening Trial

Author(s) -

Denise R. Aberle,

Sarah DeMello,

Christine D. Berg,

William C. Black,

Brenda Brewer,

Timothy R. Church,

Kathy L. Clingan,

Fenghai Duan,

Richard M. Fagerstrom,

Ilana F. Gareen,

Constantine Gatsonis,

David S. Gierada,

Amanda Jain,

Gordon C. Jones,

Irene Mahon,

Pamela M. Marcus,

Joshua M. Rathmell,

JoRean D. Sicks

Publication year - 2013

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1208962

Subject(s) - medicine , predictive value , national lung screening trial , radiography , stage (stratigraphy) , incidence (geometry) , lung cancer screening , predictive value of tests , randomized controlled trial , lung , lung cancer , nuclear medicine , positive predicative value , radiology , paleontology , physics , biology , optics

The National Lung Screening Trial was conducted to determine whether three annual screenings (rounds T0, T1, and T2) with low-dose helical computed tomography (CT), as compared with chest radiography, could reduce mortality from lung cancer. We present detailed findings from the first two incidence screenings (rounds T1 and T2).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research